Driving p53 Response to Bax Activation Greatly Enhances Sensitivity to Taxol by Inducing Massive Apoptosis
Open Access
- 1 May 2000
- Vol. 2 (3) , 202-207
- https://doi.org/10.1038/sj.neo.7900086
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Inactivation of p53 in a Human Ovarian Cancer Cell Line Increases the Sensitivity to Paclitaxel by Inducing G2/M Arrest and ApoptosisExperimental Cell Research, 1998
- Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agentsOncogene, 1998
- Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria BlockedScience, 1997
- Bax suppresses tumorigenesis and stimulates apoptosis in vivoNature, 1997
- Bax Homodimerization Is Not Required for Bax to Accelerate Chemotherapy-induced Cell DeathJournal of Biological Chemistry, 1996
- p53: upstream, downstream and off stream Review of the 8th p53 workshop (Dundee, July 5–9, 1996)Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- p53 in signaling checkpoint arrest or apoptosisCurrent Opinion in Genetics & Development, 1996
- Tumor suppressor p53 is a direct transcriptional activator of the human bax geneCell, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993